1,426
Participants
Start Date
June 22, 2023
Primary Completion Date
May 31, 2024
Study Completion Date
Perisai Husada, Bandung
Nguyen Tri Phuong Hospital, Ho Chi Minh City
Research Site, Surabaya
Lead Sponsor
AstraZeneca
INDUSTRY